Finance

Nephros reports third quarter 2006 financial results

Published in Health Business Week, December 15th, 2006

Nephros, Inc. (NEP) announced financial results for the three months and nine months, including net revenue for the quarter of $164,699, attributable to sales of its OLpur MDHDF products in Europe, compared to $225,248 in the corresponding period of 2005.

Nephros reported a net loss attributable to common stockholders in the third quarter of 2006 of $1,905,528, or $0.15 loss per basic and diluted share, compared to a loss of $1,747,882, or $0.14 loss per basic and diluted share, in the year-earlier period. The average number of basic and diluted common shares for the quarter was 12,317,992, compared to 12,307,089 for the quarter ended September 30, 2005.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Source: Health Business Week (2006-12-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry